Compare Amphastar Pharmaceuticals Inc (AMPH) vs Quantum Computing Inc (QUBT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Quantum Computing Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while Quantum Computing Inc trades at $8.95 (market cap $2.07B). The key difference: Quantum Computing Inc is far larger — about 2.4× Amphastar Pharmaceuticals Inc's market cap, and Amphastar Pharmaceuticals Inc is trading nearer its 52-week high, Quantum Computing Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | QUBT | |
|---|---|---|
Market Cap | $863.95M | $2.07B |
Sector | Health | Technology |
52-Week High | $30.81 | $24.62 |
52-Week Low | $16.87 | $6.31 |
Enterprise Value | $1.26B | $1.09B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
QUBT trades at $9.18, up 4.62% today, amid a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $5.6 million, a significant increase from the prior year, but posted a net loss. Analyst consensus is strongly bullish with a $21.33 price target, though high valuation multiples and negative margins highlight financial challenges. Recent news includes the strategic acquisition of NHanced Semiconductors, expanding manufacturing capabilities.
The outlook is speculative with substantial growth potential in quantum computing, but high execution risk persists. Investment appeal hinges on commercial traction and margin improvement, while risks include cash burn, competitive pressures, and ongoing losses. The stock offers high upside if execution succeeds, but volatility is expected.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Quantum Computing Inc
Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →
